Cardio Diagnostics shareholders elect seven directors and approve reverse stock split authorization up to 1:40

Cardio Diagnostics Holdings, Inc.

All seven director nominees elected: Dogan, Philibert, Burton, Hosseinion, Intrater, Betts, Fung.
Reverse stock split proposal approved (range 1:5 to 1:40) at board discretion within one year; 9,825,603 for, 4,015,095 against.
Proposal to issue 20%+ of common stock in non-public transactions passed; 5,617,556 for, 2,118,676 against, 6,014,546 broker non-votes.
Ratification of Prager Metis CPAs LLC as independent auditor for FY2024 approved with 12,010,406 for, 947,141 against.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.